Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. NYXH

Market Cap: $154.11M

NS

Nyxoah S.A.

NYXH
NASDAQUSD
Purchase NYXH
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin51.31%
EBITDA Margin-3.41%
EBIT Margin-3.63%
Pre-tax Margin-4.28%
Net Profit Margin-4.35%
Earnings Yield-1.30%
Valuation Multiples
Price / Book0.91
Price / Sales5.86
Price / Earnings-0.61
PEG0.14
Forward PEG0.02
EV / Sales5.35
EV / EBITDA-1.57
EV / Operating Cash Flow-1.69
EV / Free Cash Flow-1.64
Price / Free Cash Flow-1.80
Price / Operating Cash Flow-1.05
Cash Flow & Capital
Free Cash Flow / Share-$1.3
Operating Cash Flow / Share-$1.26
Free Cash Flow Yield-55.61%
Capex / Revenue9.07%
Capex / Operating Cash Flow-2.86%
Capex / Depreciation0.32
Stock Compensation / Revenue11.84%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio2.38
Quick Ratio2.31
Cash Ratio1.36
Debt / Assets0.31
Debt / Capital0.39
Debt / Equity0.63
Long-Term Debt / Capital0.25
Debt / Market Cap38.16%
Net Debt / EBITDA0.15
Solvency Ratio-1.10
Financial Leverage2.03
Efficiency & Working Capital
Asset Turnover0.13
Fixed Asset Turnover3.82
Inventory Turnover2.98
Receivables Turnover2.28
Payables Turnover1.86
Days Sales Outstanding160.37
Days Inventory Outstanding122.63
Days Payables Outstanding195.73
Operating Cycle283
Cash Conversion Cycle87.27
Working Capital Turnover0.70
Returns & Quality
Return on Equity-1.80%
Return on Assets-58.46%
Return on Invested Capital-59.89%
ROCE-71.60%
Return on Tangible Assets-81.76%
Operating Return on Assets-65.14%
Income Quality0.75
Tax Burden1.02
Interest Burden1.18
Balance Sheet & Intrinsic Metrics
Enterprise Value$121.28M
Invested Capital$119.36M
Working Capital$65.41M
Tangible Asset Value$35.09M
Net Current Asset Value$27.32M
Graham Net-Net$0.38
Book Value / Share$1.46
Tangible Book Value / Share$0.62
Cash / Share$1.72
Financial Health Scores
Piotroski Score2
Altman Z-Score-3.04
Revenue$22.65M
EBIT$-82.19M
Market Cap$129.35M
Working Capital$65.41M
Retained Earnings$-353.57M
Total Assets$168.47M
Total Liabilities$85.36M